Clinical Trial Detail

NCT ID NCT01569984
Title Radiosensitization of AVASTIN; (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Dr. Yoo-Joung Ko
Indications

colorectal cancer

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.